Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap
Molecules · 2024
DOI: 10.3390/molecules29194653 ↗At a glance
Journal article in Molecules, 2024. Written by Han Zhang and 6 co-authors. Institution: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China. Major MEDLINE topics: Histone Deacetylase Inhibitors, Pyrroles, Drug Design, Molecular Docking Simulation. Cited 2 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Youth Innovation Promotion Association, Shandong Laboratory Program.
Abstract (original language)
Drawing inspiration from the structural resemblance between a natural product N-(3-carboxypropyl)-2-acetylpyrrole and phenylbutyric acid, a pioneer HDAC inhibitor evaluated in clinical trials, we embarked on the design and synthesis of a novel array of HDAC inhibitors containing an N-linked 2-acetylpyrrole cap by utilizing the pharmacophore fusion strategy. Among them, compound 20 exhibited potential inhibitory activity on HDAC1, and demonstrated notable potency against RPMI-8226 cells with an IC50 value of 2.89 ± 0.43 μM, which was better than chidamide (IC50 = 10.23 ± 1.02 μM). Western blot analysis and Annexin V-FTIC/propidium iodide (PI) staining showed that 20 could enhance the acetylation of histone H3, as well as remarkably induce apoptosis of RPMI-8226 cancer cells. The docking study highlighted the presence of a hydrogen bond between the carbonyl oxygen of the 2-acetylpyrrole cap group and Phe198 of the HDAC1 enzyme in 20, emphasizing the crucial role of introducing this natural product-inspired cap group. Molecular dynamics simulations showed that the docked complex had good conformational stability. The ADME parameters calculation showed that 20 possesses remarkable theoretical drug-likeness properties. Taken together, these results suggested that 20 is worthy of further exploration as a potential HDAC-targeted anticancer drug candidate.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.
- State Key Laboratory of Drug Research, Ethnomedicine and Biofunctional Molecule Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
- State Key Laboratory of Chemical Biology, Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, 198 East Binhai Road, Yantai 264117, China.
ORCID profiles: Qianqian Shen
Funding
- National Natural Science Foundation of China
- Youth Innovation Promotion Association
- Shandong Laboratory Program
- Shanghai Institute of Materia Medica
- Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)
- Shanghai Institute of Materia Medica of CAS
Cite
APA
Zhang, H., Shen, Q., Hu, Z., Wu, P. Q., Chen, Y., Zhao, J. X., & Yue, J. M. (2024). Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap. Molecules. https://doi.org/10.3390/molecules29194653
Vancouver
Zhang H, Shen Q, Hu Z, Wu PQ, Chen Y, Zhao JX, et al. Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap. Molecules. 2024. doi:10.3390/molecules29194653
BibTeX
@article{Zhang2024,
author = {Zhang, Han and Shen, Qianqian and Hu, Zhu and Wu, Pei-Qian and Chen, Yi and Zhao, Jin-Xin and Yue, Jian-Min},
title = {Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29194653}
}
EUVIMED